Needham & Company Reiterates Buy on Cidara Therapeutics (CDTX) Following 2Q Report
Go back to Needham & Company Reiterates Buy on Cidara Therapeutics (CDTX) Following 2Q Report| Fidelity Advisor Small Cap independence Fund Class T (NASDAQ: CDTX) | Delayed: 0.72 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.72 | 52 Week High | $18.07 | |||
| Open | $0.72 | 52 Week Low | $8.65 | |||
| Day High | $0.75 | P/E | N/A | |||
| Day Low | $0.72 | EPS | $0.00 | |||
| Volume | 274,214 | |||||
